vs

Side-by-side financial comparison of ILLUMINA, INC. (ILMN) and Marvell Technology, Inc. (MRVL). Click either name above to swap in a different company.

Marvell Technology, Inc. is the larger business by last-quarter revenue ($2.1B vs $1.2B, roughly 1.8× ILLUMINA, INC.). Marvell Technology, Inc. runs the higher net margin — 91.7% vs 28.8%, a 62.8% gap on every dollar of revenue. On growth, Marvell Technology, Inc. posted the faster year-over-year revenue change (36.8% vs 5.0%). Marvell Technology, Inc. produced more free cash flow last quarter ($508.8M vs $267.0M). Over the past eight quarters, Marvell Technology, Inc.'s revenue compounded faster (20.6% CAGR vs -0.7%).

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

Marvell Technology, Inc. is an American company, headquartered in Santa Clara, California, which develops and produces semiconductors and related technology. Founded in 1995, the company had more than 6,500 employees as of 2024, with over 10,000 patents worldwide, and an annual revenue of $5.5 billion for fiscal 2024.

ILMN vs MRVL — Head-to-Head

Bigger by revenue
MRVL
MRVL
1.8× larger
MRVL
$2.1B
$1.2B
ILMN
Growing faster (revenue YoY)
MRVL
MRVL
+31.8% gap
MRVL
36.8%
5.0%
ILMN
Higher net margin
MRVL
MRVL
62.8% more per $
MRVL
91.7%
28.8%
ILMN
More free cash flow
MRVL
MRVL
$241.8M more FCF
MRVL
$508.8M
$267.0M
ILMN
Faster 2-yr revenue CAGR
MRVL
MRVL
Annualised
MRVL
20.6%
-0.7%
ILMN

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ILMN
ILMN
MRVL
MRVL
Revenue
$1.2B
$2.1B
Net Profit
$334.0M
$1.9B
Gross Margin
65.5%
51.6%
Operating Margin
17.4%
17.2%
Net Margin
28.8%
91.7%
Revenue YoY
5.0%
36.8%
Net Profit YoY
185.5%
381.1%
EPS (diluted)
$2.16
$2.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILMN
ILMN
MRVL
MRVL
Q4 25
$1.2B
$2.1B
Q3 25
$2.0B
Q2 25
$1.9B
Q1 25
$1.8B
Q4 24
$1.1B
$1.5B
Q3 24
$1.1B
$1.3B
Q2 24
$1.1B
$1.2B
Q1 24
$1.1B
$1.4B
Net Profit
ILMN
ILMN
MRVL
MRVL
Q4 25
$334.0M
$1.9B
Q3 25
$194.8M
Q2 25
$177.9M
Q1 25
$200.2M
Q4 24
$186.0M
$-676.3M
Q3 24
$705.0M
$-193.3M
Q2 24
$-2.0B
$-215.6M
Q1 24
$-126.0M
$-392.7M
Gross Margin
ILMN
ILMN
MRVL
MRVL
Q4 25
65.5%
51.6%
Q3 25
50.4%
Q2 25
50.3%
Q1 25
50.5%
Q4 24
65.9%
23.0%
Q3 24
69.0%
46.2%
Q2 24
64.8%
45.5%
Q1 24
62.0%
46.6%
Operating Margin
ILMN
ILMN
MRVL
MRVL
Q4 25
17.4%
17.2%
Q3 25
14.5%
Q2 25
14.3%
Q1 25
12.9%
Q4 24
15.8%
-46.4%
Q3 24
68.6%
-7.9%
Q2 24
-147.2%
-13.1%
Q1 24
-10.3%
-2.3%
Net Margin
ILMN
ILMN
MRVL
MRVL
Q4 25
28.8%
91.7%
Q3 25
9.7%
Q2 25
9.4%
Q1 25
11.0%
Q4 24
16.8%
-44.6%
Q3 24
65.3%
-15.2%
Q2 24
-178.8%
-18.6%
Q1 24
-11.7%
-27.5%
EPS (diluted)
ILMN
ILMN
MRVL
MRVL
Q4 25
$2.16
$2.20
Q3 25
$0.22
Q2 25
$0.20
Q1 25
$0.23
Q4 24
$1.16
$-0.78
Q3 24
$4.42
$-0.22
Q2 24
$-12.48
$-0.25
Q1 24
$-0.79
$-0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILMN
ILMN
MRVL
MRVL
Cash + ST InvestmentsLiquidity on hand
$1.6B
$2.7B
Total DebtLower is stronger
$4.5B
Stockholders' EquityBook value
$2.7B
$14.1B
Total Assets
$6.6B
$21.6B
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILMN
ILMN
MRVL
MRVL
Q4 25
$1.6B
$2.7B
Q3 25
$1.2B
Q2 25
$885.9M
Q1 25
$948.3M
Q4 24
$93.0M
$868.1M
Q3 24
$70.0M
$808.7M
Q2 24
$74.0M
$847.7M
Q1 24
$950.8M
Total Debt
ILMN
ILMN
MRVL
MRVL
Q4 25
$4.5B
Q3 25
$4.5B
Q2 25
$4.2B
Q1 25
$4.1B
Q4 24
$4.1B
Q3 24
$4.1B
Q2 24
$4.1B
Q1 24
$4.2B
Stockholders' Equity
ILMN
ILMN
MRVL
MRVL
Q4 25
$2.7B
$14.1B
Q3 25
$13.4B
Q2 25
$13.3B
Q1 25
$13.4B
Q4 24
$2.4B
$13.4B
Q3 24
$2.1B
$14.2B
Q2 24
$1.4B
$14.5B
Q1 24
$5.7B
$14.8B
Total Assets
ILMN
ILMN
MRVL
MRVL
Q4 25
$6.6B
$21.6B
Q3 25
$20.6B
Q2 25
$20.0B
Q1 25
$20.2B
Q4 24
$6.3B
$19.7B
Q3 24
$6.0B
$20.3B
Q2 24
$6.1B
$20.5B
Q1 24
$10.0B
$21.2B
Debt / Equity
ILMN
ILMN
MRVL
MRVL
Q4 25
0.32×
Q3 25
0.33×
Q2 25
0.32×
Q1 25
0.30×
Q4 24
0.31×
Q3 24
0.29×
Q2 24
0.29×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILMN
ILMN
MRVL
MRVL
Operating Cash FlowLast quarter
$321.0M
$582.3M
Free Cash FlowOCF − Capex
$267.0M
$508.8M
FCF MarginFCF / Revenue
23.0%
24.5%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
0.96×
0.31×
TTM Free Cash FlowTrailing 4 quarters
$935.0M
$1.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILMN
ILMN
MRVL
MRVL
Q4 25
$321.0M
$582.3M
Q3 25
$461.6M
Q2 25
$332.9M
Q1 25
$514.0M
Q4 24
$364.0M
$536.3M
Q3 24
$316.0M
$306.4M
Q2 24
$80.0M
$324.5M
Q1 24
$77.0M
$546.6M
Free Cash Flow
ILMN
ILMN
MRVL
MRVL
Q4 25
$267.0M
$508.8M
Q3 25
$414.1M
Q2 25
$214.1M
Q1 25
$444.1M
Q4 24
$335.0M
$461.3M
Q3 24
$284.0M
$258.2M
Q2 24
$49.0M
$233.0M
Q1 24
$41.0M
$475.6M
FCF Margin
ILMN
ILMN
MRVL
MRVL
Q4 25
23.0%
24.5%
Q3 25
20.6%
Q2 25
11.3%
Q1 25
24.4%
Q4 24
30.3%
30.4%
Q3 24
26.3%
20.3%
Q2 24
4.4%
20.1%
Q1 24
3.8%
33.3%
Capex Intensity
ILMN
ILMN
MRVL
MRVL
Q4 25
3.5%
Q3 25
2.4%
Q2 25
6.3%
Q1 25
3.8%
Q4 24
2.6%
4.9%
Q3 24
3.0%
3.8%
Q2 24
2.8%
7.9%
Q1 24
3.3%
5.0%
Cash Conversion
ILMN
ILMN
MRVL
MRVL
Q4 25
0.96×
0.31×
Q3 25
2.37×
Q2 25
1.87×
Q1 25
2.57×
Q4 24
1.96×
Q3 24
0.45×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ILMN
ILMN

Product revenue$990.0M85%
Service and other revenue$169.0M15%

MRVL
MRVL

Segment breakdown not available.

Related Comparisons